Director of Rutgers Stem Cell Research Center, Dr. Martin, says these layoffs aren't a sign of less money available for stem cell research in the state – even if there's little money for it from the state.
Grumet says companies like Johnson and Johnson are still very interested in stem cells and may be reorganizing rather than cutting research.
But Senator Robert Singer, who has worked to fund stem cell research through legislation, says New Jersey will not be a leader in it because as companies cut jobs here, they add more to the ranks in other states like California. Singer says New Jersey used to be a welcoming place for big pharmaceutical companies, but not anymore.